Hyundai Bioscience Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.hyundaibioscience.com

Country

South Korea

Exchange

KOSDAQ

Founded 2000

Hyundai Bioscience is a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. Founded in 2000, the company is based in Seoul, South Korea.

Key Stats

52-Week Range

₩4565.00₩21500.00

Beta0.86

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.